Retatrutide 20mg

$229.00

Retatrutide (LY3437943) is a synthetic tri-agonist peptide targeting GIP, GLP-1, and GLP-2 receptors. Supplied as analytical-grade lyophilised research material for in-vitro receptor binding and downstream signalling pathway research. Not approved for human use. Not a therapeutic agent.

Out of stock

Notify me when stock available

SKU: RT20 Category:

  • Formula: C230H341N57O68

  • Molecular Weight (MW): 4967.5 g/mol
  • Dose: 20 mg
  • Form: Lyophilised powder
  • Purity: ≥98% (HPLC)
  • Storage: −20°C
  • Documentation: COA + HPLC + Mass Spec

Research Use Declaration
This material is supplied exclusively for in-vitro and pre-clinical laboratory research purposes. It is not a therapeutic good and has not been approved by the Therapeutic Goods Administration (TGA) for any clinical or human use. By purchasing, you confirm you are a qualified research buyer and that this material will be used solely for legitimate non-clinical laboratory research.

Batch Documentation & Records
Every batch is independently tested by a third-party analytical laboratory. Certificate of Analysis (COA), HPLC purity report, and mass spectrometry identity verification are available for each batch.

Access batch documentation

Shopping Cart
Scroll to Top